_id
6915e823bc934aba376b1b46
Ticker
PSNL
Name
Personalis Inc
Exchange
NASDAQ
Address
6600 Dumbarton Circle, Fremont, CA, United States, 94555
Country
USA
Sector
Healthcare
Industry
Diagnostics & Research
Currency
USD
Website
https://www.personalis.com
Description
Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally. The company offers NeXT Personal, a tumor-informed liquid biopsy test for detection of minimal residual disease (MRD), therapy response and recurrence monitoring in solid tumor cancers; and ImmunoID NeXT, a tissue-based service that combines whole exome and whole transcriptome sequencing data with advanced analytics to provide a multi-dimensional view of the tumor and the tumor microenvironment from a single sample. It also provides NeXT Personal Dx, a tumor-informed liquid biopsy test for the detection of MRD; and NeXT Dx, a tumor profiling test that is used to help select therapy for a cancer patient and identify potential clinical trials for a patient. In addition, the company performs whole exome sequencing of cancer tissue and matched blood samples for diagnostic companies as an input to their products; and whole genome sequencing on human samples for research projects, such as population sequencing initiatives. Its services are used by pharmaceutical companies for translational research, biomarker discovery, the development of personalized cancer therapies, and for clinical trials, as well as tests are used by physicians to detect residual or recurrent cancer in patients, monitor cancer response to therapy, and uncover insights for therapy selection. The company's customers include pharmaceutical companies, biopharmaceutical companies, diagnostics companies, universities, non-profits, government entities, and patients. The company has strategic collaboration with Tempus AI, Inc. to bring ultra-sensitive cancer recurrence testing to colorectal cancer patients. Personalis, Inc. was incorporated in 2011 and is headquartered in Fremont, California.
Last Close
9.28
Volume
1081133
Current Price
8.77
Change
-5.495689655172412
Last Updated
2025-12-03T12:26:28.456Z
Image
data:image/webp;base64,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
Ipo Date
2019-06-20T00:00:00.000Z
Market Cap
896923968
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.983
Sentiment Sources
1
Rating
4.4286
Target Price
11
Strong Buy
4
Buy
2
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
14495000
Cost Of Revenue
12581000
Gross Profit
1914000
Operating Expenses
25205000
Operating Income
-23291000
Interest Expense
64000
Pretax Income
-21649000
Net Income
-21652000
Eps
-0.2441061119302285
Dividends Per Share
-
Shares Outstanding
88804348
Income Tax Expense
3000
EBITDA
-19183000
Operating Margin
-160.68299413590893
Total Other Income Expense Net
1642000
Cash
49973000
Short Term Investments
100542000
Receivables
14376000
Inventories
3729000
Total Current Assets
174402000
Property Plant Equipment
62252000
Total Assets
242839000
Payables
11147000
Short Term Debt
8373000
Long Term Debt
-
Total Liabilities
71424000
Equity
171415000
Depreciation
2466000
Change In Working Capital
-4197000
Cash From Operations
-21804000
Capital Expenditures
1626000
Cash From Investing
18724000
Cash From Financing
-317000
Net Change In Cash
-3401000
PE
-
PB
4.538058973077035
ROE
-12.63133331388735
ROA
-8.916195504017065
FCF
-23430000
Fcf Percent
-1.6164194549844775
Piotroski FScore
0
Health Score
29
Deep Value Investing Score
3.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
2.5
Growth Investing Score
1
Momentum Investing Score
4
Net Net Investing Score
2.5
Quality Investing Score
3
Value Investing Score
3.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
14495000
Quarters > 0 > income Statement > cost Of Revenue
12581000
Quarters > 0 > income Statement > gross Profit
1914000
Quarters > 0 > income Statement > operating Expenses
25205000
Quarters > 0 > income Statement > operating Income
-23291000
Quarters > 0 > income Statement > interest Expense
64000
Quarters > 0 > income Statement > pretax Income
-21649000
Quarters > 0 > income Statement > net Income
-21652000
Quarters > 0 > income Statement > eps
-0.2441061119302285
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
88699131
Quarters > 0 > income Statement > income Tax Expense
3000
Quarters > 0 > income Statement > EBITDA
-19183000
Quarters > 0 > income Statement > operating Margin
-160.68299413590893
Quarters > 0 > income Statement > total Other Income Expense Net
1642000
Quarters > 0 > balance Sheet > cash
49973000
Quarters > 0 > balance Sheet > short Term Investments
100542000
Quarters > 0 > balance Sheet > receivables
14376000
Quarters > 0 > balance Sheet > inventories
3729000
Quarters > 0 > balance Sheet > total Current Assets
174402000
Quarters > 0 > balance Sheet > property Plant Equipment
62252000
Quarters > 0 > balance Sheet > total Assets
242839000
Quarters > 0 > balance Sheet > payables
11147000
Quarters > 0 > balance Sheet > short Term Debt
8373000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
71424000
Quarters > 0 > balance Sheet > equity
171415000
Quarters > 0 > cash Flow > net Income
-21652000
Quarters > 0 > cash Flow > depreciation
2466000
Quarters > 0 > cash Flow > change In Working Capital
-4197000
Quarters > 0 > cash Flow > cash From Operations
-21804000
Quarters > 0 > cash Flow > capital Expenditures
1626000
Quarters > 0 > cash Flow > cash From Investing
18724000
Quarters > 0 > cash Flow > cash From Financing
-317000
Quarters > 0 > cash Flow > net Change In Cash
-3401000
Quarters > 0 > ratios > PE
-0.2441061119302285
Quarters > 0 > ratios > PB
4.538058973077035
Quarters > 0 > ratios > ROE
-12.63133331388735
Quarters > 0 > ratios > ROA
-8.916195504017065
Quarters > 0 > ratios > FCF
-23430000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-1.6164194549844775
Quarters > 0 > health Score
29
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
17203000
Quarters > 1 > income Statement > cost Of Revenue
12447000
Quarters > 1 > income Statement > gross Profit
4756000
Quarters > 1 > income Statement > operating Expenses
26560000
Quarters > 1 > income Statement > operating Income
-21804000
Quarters > 1 > income Statement > interest Expense
48000
Quarters > 1 > income Statement > pretax Income
-20054000
Quarters > 1 > income Statement > net Income
-20056000
Quarters > 1 > income Statement > eps
-0.22657667075045435
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
88517498
Quarters > 1 > income Statement > income Tax Expense
2000
Quarters > 1 > income Statement > EBITDA
-17475000
Quarters > 1 > income Statement > operating Margin
-126.74533511596815
Quarters > 1 > income Statement > total Other Income Expense Net
1750000
Quarters > 1 > balance Sheet > cash
53374000
Quarters > 1 > balance Sheet > short Term Investments
119858000
Quarters > 1 > balance Sheet > receivables
9952000
Quarters > 1 > balance Sheet > inventories
4564000
Quarters > 1 > balance Sheet > total Current Assets
193343000
Quarters > 1 > balance Sheet > property Plant Equipment
61466000
Quarters > 1 > balance Sheet > total Assets
258680000
Quarters > 1 > balance Sheet > payables
9926000
Quarters > 1 > balance Sheet > short Term Debt
9048000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
67851000
Quarters > 1 > balance Sheet > equity
190829000
Quarters > 1 > cash Flow > net Income
-20056000
Quarters > 1 > cash Flow > depreciation
2531000
Quarters > 1 > cash Flow > change In Working Capital
2365000
Quarters > 1 > cash Flow > cash From Operations
-12935000
Quarters > 1 > cash Flow > capital Expenditures
290000
Quarters > 1 > cash Flow > cash From Investing
-4371000
Quarters > 1 > cash Flow > cash From Financing
-327000
Quarters > 1 > cash Flow > net Change In Cash
-17627000
Quarters > 1 > ratios > PE
-0.22657667075045435
Quarters > 1 > ratios > PB
4.068031889597493
Quarters > 1 > ratios > ROE
-10.509932976644011
Quarters > 1 > ratios > ROA
-7.753208597494974
Quarters > 1 > ratios > FCF
-13225000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.7687612625704819
Quarters > 1 > health Score
30
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
20605000
Quarters > 2 > income Statement > cost Of Revenue
13398000
Quarters > 2 > income Statement > gross Profit
7207000
Quarters > 2 > income Statement > operating Expenses
24903000
Quarters > 2 > income Statement > operating Income
-17696000
Quarters > 2 > income Statement > interest Expense
28000
Quarters > 2 > income Statement > pretax Income
-15743000
Quarters > 2 > income Statement > net Income
-15750000
Quarters > 2 > income Statement > eps
-0.18007432439114726
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
87463885
Quarters > 2 > income Statement > income Tax Expense
7000
Quarters > 2 > income Statement > EBITDA
-13128000
Quarters > 2 > income Statement > operating Margin
-85.88206745935453
Quarters > 2 > income Statement > total Other Income Expense Net
1953000
Quarters > 2 > balance Sheet > cash
71001000
Quarters > 2 > balance Sheet > short Term Investments
114687000
Quarters > 2 > balance Sheet > receivables
10973000
Quarters > 2 > balance Sheet > inventories
4212000
Quarters > 2 > balance Sheet > total Current Assets
206422000
Quarters > 2 > balance Sheet > property Plant Equipment
64041000
Quarters > 2 > balance Sheet > total Assets
273308000
Quarters > 2 > balance Sheet > payables
7914000
Quarters > 2 > balance Sheet > short Term Debt
10306000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
65963000
Quarters > 2 > balance Sheet > equity
207345000
Quarters > 2 > cash Flow > net Income
-15750000
Quarters > 2 > cash Flow > depreciation
2587000
Quarters > 2 > cash Flow > change In Working Capital
-5954000
Quarters > 2 > cash Flow > cash From Operations
-17961000
Quarters > 2 > cash Flow > capital Expenditures
2511000
Quarters > 2 > cash Flow > cash From Investing
-22542000
Quarters > 2 > cash Flow > cash From Financing
20087000
Quarters > 2 > cash Flow > net Change In Cash
-20414000
Quarters > 2 > ratios > PE
-0.18007432439114726
Quarters > 2 > ratios > PB
3.6994297979213386
Quarters > 2 > ratios > ROE
-7.596035592852492
Quarters > 2 > ratios > ROA
-5.762729228562647
Quarters > 2 > ratios > FCF
-20472000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-0.9935452560058239
Quarters > 2 > health Score
29
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
16800000
Quarters > 3 > income Statement > cost Of Revenue
12250000
Quarters > 3 > income Statement > gross Profit
4550000
Quarters > 3 > income Statement > operating Expenses
22662000
Quarters > 3 > income Statement > operating Income
-18112000
Quarters > 3 > income Statement > interest Expense
1000
Quarters > 3 > income Statement > pretax Income
-16421000
Quarters > 3 > income Statement > net Income
-16425000
Quarters > 3 > income Statement > eps
-0.22537221610770972
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
72879436
Quarters > 3 > income Statement > income Tax Expense
4000
Quarters > 3 > income Statement > EBITDA
-13879000
Quarters > 3 > income Statement > operating Margin
-107.8095238095238
Quarters > 3 > income Statement > total Other Income Expense Net
1691000
Quarters > 3 > balance Sheet > cash
91415000
Quarters > 3 > balance Sheet > short Term Investments
93594000
Quarters > 3 > balance Sheet > receivables
8140000
Quarters > 3 > balance Sheet > inventories
3976000
Quarters > 3 > balance Sheet > total Current Assets
203015000
Quarters > 3 > balance Sheet > property Plant Equipment
64727000
Quarters > 3 > balance Sheet > total Assets
270268000
Quarters > 3 > balance Sheet > payables
6397000
Quarters > 3 > balance Sheet > short Term Debt
9365000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
67311000
Quarters > 3 > balance Sheet > equity
202957000
Quarters > 3 > cash Flow > net Income
-16425000
Quarters > 3 > cash Flow > depreciation
2543000
Quarters > 3 > cash Flow > change In Working Capital
3858000
Quarters > 3 > cash Flow > cash From Operations
-7796000
Quarters > 3 > cash Flow > capital Expenditures
1246000
Quarters > 3 > cash Flow > cash From Investing
-26183000
Quarters > 3 > cash Flow > cash From Financing
49601000
Quarters > 3 > cash Flow > net Change In Cash
15615000
Quarters > 3 > ratios > PE
-0.22537221610770972
Quarters > 3 > ratios > PB
3.149202312411003
Quarters > 3 > ratios > ROE
-8.092847253359086
Quarters > 3 > ratios > ROA
-6.077301049328814
Quarters > 3 > ratios > FCF
-9042000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.5382142857142858
Quarters > 3 > health Score
30
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
84614000
Annuals > 0 > income Statement > cost Of Revenue
57789000
Annuals > 0 > income Statement > gross Profit
26825000
Annuals > 0 > income Statement > operating Expenses
95092000
Annuals > 0 > income Statement > operating Income
-68267000
Annuals > 0 > income Statement > interest Expense
24000
Annuals > 0 > income Statement > pretax Income
-81266000
Annuals > 0 > income Statement > net Income
-81284000
Annuals > 0 > income Statement > eps
-1.3718584018133158
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
59251013
Annuals > 0 > income Statement > income Tax Expense
18000
Annuals > 0 > income Statement > EBITDA
-70301000
Annuals > 0 > income Statement > operating Margin
-80.68050204457892
Annuals > 0 > income Statement > total Other Income Expense Net
-12999000
Annuals > 0 > balance Sheet > cash
91415000
Annuals > 0 > balance Sheet > short Term Investments
93594000
Annuals > 0 > balance Sheet > receivables
8140000
Annuals > 0 > balance Sheet > inventories
3976000
Annuals > 0 > balance Sheet > total Current Assets
203015000
Annuals > 0 > balance Sheet > property Plant Equipment
64727000
Annuals > 0 > balance Sheet > total Assets
270268000
Annuals > 0 > balance Sheet > payables
6397000
Annuals > 0 > balance Sheet > short Term Debt
9365000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
67311000
Annuals > 0 > balance Sheet > equity
202957000
Annuals > 0 > cash Flow > net Income
-81284000
Annuals > 0 > cash Flow > depreciation
10941000
Annuals > 0 > cash Flow > change In Working Capital
-2592000
Annuals > 0 > cash Flow > cash From Operations
-45150000
Annuals > 0 > cash Flow > capital Expenditures
1603000
Annuals > 0 > cash Flow > cash From Investing
-35069000
Annuals > 0 > cash Flow > cash From Financing
114672000
Annuals > 0 > cash Flow > net Change In Cash
34431000
Annuals > 0 > ratios > PE
-1.3718584018133158
Annuals > 0 > ratios > PB
2.9485813807850922
Annuals > 0 > ratios > ROE
-40.04986277881522
Annuals > 0 > ratios > ROA
-30.075332632794115
Annuals > 0 > ratios > FCF
-46753000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.5525444961826648
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
73481000
Annuals > 1 > income Statement > cost Of Revenue
55273000
Annuals > 1 > income Statement > gross Profit
18208000
Annuals > 1 > income Statement > operating Expenses
128144000
Annuals > 1 > income Statement > operating Income
-109936000
Annuals > 1 > income Statement > interest Expense
110000
Annuals > 1 > income Statement > pretax Income
-108213000
Annuals > 1 > income Statement > net Income
-108296000
Annuals > 1 > income Statement > eps
-2.2479615601396246
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
48175201
Annuals > 1 > income Statement > income Tax Expense
83000
Annuals > 1 > income Statement > EBITDA
-96807000
Annuals > 1 > income Statement > operating Margin
-149.61146418802142
Annuals > 1 > income Statement > total Other Income Expense Net
1723000
Annuals > 1 > balance Sheet > cash
56984000
Annuals > 1 > balance Sheet > short Term Investments
57195000
Annuals > 1 > balance Sheet > receivables
17730000
Annuals > 1 > balance Sheet > inventories
5661000
Annuals > 1 > balance Sheet > total Current Assets
146744000
Annuals > 1 > balance Sheet > property Plant Equipment
75218000
Annuals > 1 > balance Sheet > total Assets
225099000
Annuals > 1 > balance Sheet > payables
14920000
Annuals > 1 > balance Sheet > short Term Debt
9407000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
95658000
Annuals > 1 > balance Sheet > equity
129441000
Annuals > 1 > cash Flow > net Income
-108296000
Annuals > 1 > cash Flow > depreciation
11296000
Annuals > 1 > cash Flow > change In Working Capital
13482000
Annuals > 1 > cash Flow > cash From Operations
-56258000
Annuals > 1 > cash Flow > capital Expenditures
10911000
Annuals > 1 > cash Flow > cash From Investing
13099000
Annuals > 1 > cash Flow > cash From Financing
11031000
Annuals > 1 > cash Flow > net Change In Cash
-32144000
Annuals > 1 > ratios > PE
-2.2479615601396246
Annuals > 1 > ratios > PB
3.7590062661753234
Annuals > 1 > ratios > ROE
-83.66437218501093
Annuals > 1 > ratios > ROA
-48.110386985282034
Annuals > 1 > ratios > FCF
-67169000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-0.9141002436003864
Annuals > 1 > health Score
26
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
65047000
Annuals > 2 > income Statement > cost Of Revenue
51697000
Annuals > 2 > income Statement > gross Profit
13350000
Annuals > 2 > income Statement > operating Expenses
128881000
Annuals > 2 > income Statement > operating Income
-115531000
Annuals > 2 > income Statement > interest Expense
201000
Annuals > 2 > income Statement > pretax Income
-113275000
Annuals > 2 > income Statement > net Income
-113315000
Annuals > 2 > income Statement > eps
-2.479279804388182
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
45704805
Annuals > 2 > income Statement > income Tax Expense
40000
Annuals > 2 > income Statement > EBITDA
-104642000
Annuals > 2 > income Statement > operating Margin
-177.61157317016927
Annuals > 2 > income Statement > total Other Income Expense Net
2256000
Annuals > 2 > balance Sheet > cash
89128000
Annuals > 2 > balance Sheet > short Term Investments
78530000
Annuals > 2 > balance Sheet > receivables
16642000
Annuals > 2 > balance Sheet > inventories
6384000
Annuals > 2 > balance Sheet > total Current Assets
199699000
Annuals > 2 > balance Sheet > property Plant Equipment
88415000
Annuals > 2 > balance Sheet > total Assets
292700000
Annuals > 2 > balance Sheet > payables
12854000
Annuals > 2 > balance Sheet > short Term Debt
7609000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
74561000
Annuals > 2 > balance Sheet > equity
218139000
Annuals > 2 > cash Flow > net Income
-113315000
Annuals > 2 > cash Flow > depreciation
8432000
Annuals > 2 > cash Flow > change In Working Capital
10611000
Annuals > 2 > cash Flow > cash From Operations
-70233000
Annuals > 2 > cash Flow > capital Expenditures
49896000
Annuals > 2 > cash Flow > cash From Investing
52537000
Annuals > 2 > cash Flow > cash From Financing
1366000
Annuals > 2 > cash Flow > net Change In Cash
-16457000
Annuals > 2 > ratios > PE
-2.479279804388182
Annuals > 2 > ratios > PB
2.1161668958783157
Annuals > 2 > ratios > ROE
-51.94623611550433
Annuals > 2 > ratios > ROA
-38.713700034164674
Annuals > 2 > ratios > FCF
-120129000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-1.8468030808492322
Annuals > 2 > health Score
35
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
85494000
Annuals > 3 > income Statement > cost Of Revenue
53837000
Annuals > 3 > income Statement > gross Profit
31657000
Annuals > 3 > income Statement > operating Expenses
97010000
Annuals > 3 > income Statement > operating Income
-65353000
Annuals > 3 > income Statement > interest Expense
184000
Annuals > 3 > income Statement > pretax Income
-65212000
Annuals > 3 > income Statement > net Income
-65226000
Annuals > 3 > income Statement > eps
-1.4862351330345187
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
43886730
Annuals > 3 > income Statement > income Tax Expense
14000
Annuals > 3 > income Statement > EBITDA
-59014000
Annuals > 3 > income Statement > operating Margin
-76.44162163426674
Annuals > 3 > income Statement > total Other Income Expense Net
141000
Annuals > 3 > balance Sheet > cash
105585000
Annuals > 3 > balance Sheet > short Term Investments
181479000
Annuals > 3 > balance Sheet > receivables
18468000
Annuals > 3 > balance Sheet > inventories
4081000
Annuals > 3 > balance Sheet > total Current Assets
318231000
Annuals > 3 > balance Sheet > property Plant Equipment
73472000
Annuals > 3 > balance Sheet > total Assets
396528000
Annuals > 3 > balance Sheet > payables
9221000
Annuals > 3 > balance Sheet > short Term Debt
5534000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
86227000
Annuals > 3 > balance Sheet > equity
310301000
Annuals > 3 > cash Flow > net Income
-65226000
Annuals > 3 > cash Flow > depreciation
6014000
Annuals > 3 > cash Flow > change In Working Capital
-31144000
Annuals > 3 > cash Flow > cash From Operations
-70828000
Annuals > 3 > cash Flow > capital Expenditures
11083000
Annuals > 3 > cash Flow > cash From Investing
-60069000
Annuals > 3 > cash Flow > cash From Financing
169700000
Annuals > 3 > cash Flow > net Change In Cash
38850000
Annuals > 3 > ratios > PE
-1.4862351330345187
Annuals > 3 > ratios > PB
1.4284709781792517
Annuals > 3 > ratios > ROE
-21.020235190991972
Annuals > 3 > ratios > ROA
-16.4492797482145
Annuals > 3 > ratios > FCF
-81911000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-0.9580906262427773
Annuals > 3 > health Score
35
Valuation > metrics > PE
-0.2441061119302285
Valuation > metrics > PB
4.538058973077035
Valuation > final Score
34.61941026922965
Valuation > verdict
51.3% Overvalued
Profitability > metrics > ROE
-12.63133331388735
Profitability > metrics > ROA
-12.414995240880264
Profitability > metrics > Net Margin
-1.493756467747499
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.4166729866114401
Risk > metrics > Interest Coverage
-363.921875
Risk > final Score
-1396
Risk > verdict
High
Liquidity > metrics > Current Ratio
8.93452868852459
Liquidity > metrics > Quick Ratio
8.743493852459016
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
39.31968110402507
Prev Valuations > 1
43.005702020786615
Prev Valuations > 2
48.507976875889966
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-1757
Prev Risks > 1
-2468
Prev Risks > 2
-72388
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-13T01:14:32.664Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-19
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.2788
Earnings History > 0 > eps Difference
0.2788
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-04
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.24
Earnings History > 1 > eps Estimate
-0.2763
Earnings History > 1 > eps Difference
0.0363
Earnings History > 1 > surprise Percent
13.1379
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-05
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.23
Earnings History > 2 > eps Estimate
-0.24
Earnings History > 2 > eps Difference
0.01
Earnings History > 2 > surprise Percent
4.1667
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-16
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.18
Earnings History > 3 > eps Estimate
-0.25
Earnings History > 3 > eps Difference
0.07
Earnings History > 3 > surprise Percent
28
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-26
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.23
Earnings History > 4 > eps Estimate
-0.264
Earnings History > 4 > eps Difference
0.034
Earnings History > 4 > surprise Percent
12.8788
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-06
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.64
Earnings History > 5 > eps Estimate
-0.35
Earnings History > 5 > eps Difference
-0.29
Earnings History > 5 > surprise Percent
-82.8571
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-07
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.24
Earnings History > 6 > eps Estimate
-0.37
Earnings History > 6 > eps Difference
0.13
Earnings History > 6 > surprise Percent
35.1351
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-08
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.26
Earnings History > 7 > eps Estimate
-0.41
Earnings History > 7 > eps Difference
0.15
Earnings History > 7 > surprise Percent
36.5854
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-02-28
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.54
Earnings History > 8 > eps Estimate
-0.5
Earnings History > 8 > eps Difference
-0.04
Earnings History > 8 > surprise Percent
-8
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-07
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.48
Earnings History > 9 > eps Estimate
-0.53
Earnings History > 9 > eps Difference
0.05
Earnings History > 9 > surprise Percent
9.434
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-08
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.5
Earnings History > 10 > eps Estimate
-0.53
Earnings History > 10 > eps Difference
0.03
Earnings History > 10 > surprise Percent
5.6604
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-03
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.61
Earnings History > 11 > eps Estimate
-0.58
Earnings History > 11 > eps Difference
-0.03
Earnings History > 11 > surprise Percent
-5.1724
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-02-23
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.67
Earnings History > 12 > eps Estimate
-0.64
Earnings History > 12 > eps Difference
-0.03
Earnings History > 12 > surprise Percent
-4.6875
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-02
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.58
Earnings History > 13 > eps Estimate
-0.64
Earnings History > 13 > eps Difference
0.06
Earnings History > 13 > surprise Percent
9.375
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-03
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.6
Earnings History > 14 > eps Estimate
-0.63
Earnings History > 14 > eps Difference
0.03
Earnings History > 14 > surprise Percent
4.7619
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-04
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.63
Earnings History > 15 > eps Estimate
-0.58
Earnings History > 15 > eps Difference
-0.05
Earnings History > 15 > surprise Percent
-8.6207
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-02-24
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.45
Earnings History > 16 > eps Estimate
-0.5
Earnings History > 16 > eps Difference
0.05
Earnings History > 16 > surprise Percent
10
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-04
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.4
Earnings History > 17 > eps Estimate
-0.42
Earnings History > 17 > eps Difference
0.02
Earnings History > 17 > surprise Percent
4.7619
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-04
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.34
Earnings History > 18 > eps Estimate
-0.39
Earnings History > 18 > eps Difference
0.05
Earnings History > 18 > surprise Percent
12.8205
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-05
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.29
Earnings History > 19 > eps Estimate
-0.36
Earnings History > 19 > eps Difference
0.07
Earnings History > 19 > surprise Percent
19.4444
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-02-25
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.34
Earnings History > 20 > eps Estimate
-0.29
Earnings History > 20 > eps Difference
-0.05
Earnings History > 20 > surprise Percent
-17.2414
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-11-05
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.27
Earnings History > 21 > eps Estimate
-0.28
Earnings History > 21 > eps Difference
0.01
Earnings History > 21 > surprise Percent
3.5714
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-08-06
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.29
Earnings History > 22 > eps Estimate
-0.34
Earnings History > 22 > eps Difference
0.05
Earnings History > 22 > surprise Percent
14.7059
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-05-07
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.29
Earnings History > 23 > eps Estimate
-0.25
Earnings History > 23 > eps Difference
-0.04
Earnings History > 23 > surprise Percent
-16
Earnings History > 24 > period
2019-12-31
Earnings History > 24 > report Date
2020-03-25
Earnings History > 24 > date
2019-12-31
Earnings History > 24 > before After Market
AfterMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.21
Earnings History > 24 > eps Estimate
-0.25
Earnings History > 24 > eps Difference
0.04
Earnings History > 24 > surprise Percent
16
Earnings History > 25 > period
2019-09-30
Earnings History > 25 > report Date
2019-11-13
Earnings History > 25 > date
2019-09-30
Earnings History > 25 > before After Market
AfterMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.22
Earnings History > 25 > eps Estimate
-0.25
Earnings History > 25 > eps Difference
0.03
Earnings History > 25 > surprise Percent
12
Earnings History > 26 > period
2019-06-30
Earnings History > 26 > report Date
2019-08-13
Earnings History > 26 > date
2019-06-30
Earnings History > 26 > before After Market
AfterMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.89
Earnings History > 26 > eps Estimate
-0.3
Earnings History > 26 > eps Difference
-0.59
Earnings History > 26 > surprise Percent
-196.6667
Earnings History > 27 > period
2019-03-31
Earnings History > 27 > report Date
2019-06-20
Earnings History > 27 > date
2019-03-31
Earnings History > 27 > before After Market
AfterMarket
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.7
Earnings History > 27 > eps Estimate
0
Earnings History > 27 > eps Difference
-0.7
Earnings History > 27 > surprise Percent
-
Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally. The company offers NeXT Personal, a tumor-informed liquid biopsy test for detection of minimal residual disease (MRD), therapy response and recurrence monitoring in solid tumor cancers; and ImmunoID NeXT, a tissue-based service that combines whole exome and whole transcriptome sequencing data with advanced analytics to provide a multi-dimensional view of the tumor and the tumor microenvironment from a single sample. It also provides NeXT Personal Dx, a tumor-informed liquid biopsy test for the detection of MRD; and NeXT Dx, a tumor profiling test that is used to help select therapy for a cancer patient and identify potential clinical trials for a patient. In addition, the company performs whole exome sequencing of cancer tissue and matched blood samples for diagnostic companies as an input to their products; and whole genome sequencing on human samples for research projects, such as population sequencing initiatives. Its services are used by pharmaceutical companies for translational research, biomarker discovery, the development of personalized cancer therapies, and for clinical trials, as well as tests are used by physicians to detect residual or recurrent cancer in patients, monitor cancer response to therapy, and uncover insights for therapy selection. The company's customers include pharmaceutical companies, biopharmaceutical companies, diagnostics companies, universities, non-profits, government entities, and patients. The company has strategic collaboration with Tempus AI, Inc. to bring ultra-sensitive cancer recurrence testing to colorectal cancer patients. Personalis, Inc. was incorporated in 2011 and is headquartered in Fremont, California.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/APersonalis (Nasdaq: PSNL) Cell study follows 431 lung cancer patients with NeXT Personal Stock Titan
Read more →Why Analysts See Personalis Story Shifting With Medicare Tailwinds And Biopharma Headwinds Yahoo Finance
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$11
Analyst Picks
Strong Buy
4
Buy
2
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 91.35% of the total shares of Personalis Inc
1.
Merck & Co Inc(15.8383%)
since
2025/06/30
2.
Lightspeed Management Co LLC(9.2028%)
since
2025/06/30
3.
ARK Genomic Revolution ETF(9.1005%)
since
2025/08/28
4.
ARK Investment Management LLC(8.0155%)
since
2025/06/30
5.
ARK Genomic Revolution(7.8418%)
since
2025/06/30
6.
BlackRock Inc(5.8685%)
since
2025/06/30
7.
AIGH Capital Management, LLC(4.1995%)
since
2025/06/30
8.
Vanguard Group Inc(3.5376%)
since
2025/06/30
9.
Aberdeen Group PLC(1.9842%)
since
2025/06/30
10.
Vanguard Total Stock Mkt Idx Inv(1.9667%)
since
2025/07/31
11.
Blue Water Life Science Advisors, LLC(1.8903%)
since
2025/06/30
12.
Geode Capital Management, LLC(1.54%)
since
2025/06/30
13.
T. Rowe Price Investment Management,Inc.(1.4259%)
since
2025/06/30
14.
iShares Russell 2000 ETF(1.3961%)
since
2025/08/31
15.
abrdn Healthcare Investors(1.3279%)
since
2025/08/31
16.
Millennium Management LLC(1.23%)
since
2025/06/30
17.
abrdn Life Sciences Investors(1.1411%)
since
2025/08/31
18.
Dimensional Fund Advisors, Inc.(0.8851%)
since
2025/06/30
19.
T. Rowe Price Small-Cap Value(0.8616%)
since
2025/07/31
20.
T. Rowe Price Small-Cap Stock(0.8228%)
since
2025/07/31
21.
State Street Corp(0.7754%)
since
2025/06/30
22.
Vanguard Institutional Extnd Mkt Idx Tr(0.7579%)
since
2025/07/31
23.
Kennedy Capital Management Inc(0.7368%)
since
2025/06/30
24.
Sumitomo Mitsui Trust Group Inc(0.7222%)
since
2025/06/30
25.
Nuveen, LLC(0.7167%)
since
2025/06/30
26.
Amova Asset Management Americas, Inc(0.7153%)
since
2025/06/30
27.
Morgan Stanley - Brokerage Accounts(0.7064%)
since
2025/06/30
28.
BlackRock Advantage Small Cap Core Instl(0.6912%)
since
2025/07/31
29.
Renaissance Technologies Corp(0.6352%)
since
2025/06/30
30.
Kennedy Micro Cap(0.577%)
since
2025/06/30
31.
Fidelity Small Cap Index(0.5668%)
since
2025/06/30
32.
State Treasurer State Of Michigan(0.5568%)
since
2025/06/30
33.
T. Rowe Price U.S. SC Value Eq Tr-D(0.5247%)
since
2025/06/30
34.
iShares Russell 2000 Value ETF(0.4905%)
since
2025/08/31
35.
T. Rowe Price Instl Small-Cap Stock(0.4166%)
since
2025/07/31
36.
Fidelity Extended Market Index(0.3783%)
since
2025/07/31
37.
Nuveen Quant Small Cap Equity R6(0.3603%)
since
2025/07/31
38.
iShares Biotechnology ETF(0.3513%)
since
2025/08/31
39.
Columbia Trust US Smaller Companies Fund(0.3082%)
since
2025/06/30
40.
Bruce(0.2853%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.2788
Date
2025-09-30
EPS Actual
-0.24
EPS Estimate
-0.2763
EPS Difference
0.0363
Surprise Percent
13.1379%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.